Patents by Inventor Go Kito

Go Kito has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5300639
    Abstract: New thiazolo[5,4-b]azepine compounds represented by ##STR1## wherein R.sup.1 is a hydrogen atom, an aliphatic group which may be substituted, a carboxylic acyl group which may be substituted or a sulfonic acyl group which may be substituted; R.sup.2 is a hydrogen atom, an aromatic group which may be substituted or an aliphatic group which may be substituted, which are capable of e.g., inhibiting lipoperoxide formation.
    Type: Grant
    Filed: March 17, 1992
    Date of Patent: April 5, 1994
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Tetsuya Aono, Masahiro Suno, Go Kito
  • Patent number: 5202354
    Abstract: A novel composition and method are disclosed for reducing acetaldehyde toxicity, especially for preventing and relieving hangover symptoms in humans. The composition comprises (a) a compound of the formula: ##STR1## wherein R is hydrogen or an acyl group; R' is thiol or sulfonic group; and n is an integer of 1 or 2, (b) ascorbic acid or a salt thereof and (c) a disulfide type thiamine derivative or a salt thereof. The composition is orally administered, preferably in the form of tablets.
    Type: Grant
    Filed: February 21, 1992
    Date of Patent: April 13, 1993
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Masayoshi Matsuoka, Go Kito
  • Patent number: 5153201
    Abstract: A novel condensed thiazole derivative of the formula [I]: ##STR1## wherein A is a single bond or CH.sub.2 ; R.sup.1 is hydrogen atom, or an optionally substituted aliphatic, carboxylic acyl or sulfonic acyl group; and R.sup.2 is hydrogen atom, or an optionally substituted aromatic cyclic or aliphatic group, or a salt thereof. The compound [I] is useful for medicines for preventing and treating various diseases such as cancer, arterial sclerosis, hepatopathy, cerebrovascular diseases, inflammatory and the like. A process of the compound of the formula [I] or a salt thereof and a pharmaceutical composition comprising the compound of the formula [I] or a pharmaceutically acceptable salt thereof as an active component are also disclosed.
    Type: Grant
    Filed: February 22, 1991
    Date of Patent: October 6, 1992
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Tetsuya Aono, Masahiro Suno, Go Kito
  • Patent number: 5118806
    Abstract: New thiazolo[5,4-b]azepine compounds represented by ##STR1## wherein R.sup.1 is a hydrogen atom, an aliphatic group which may be substituted, a carboxylic acyl group which may be substituted or a sulfonic acyl group which may be substituted; R.sup.2 is a hydrogen atom, an aromatic group which may be substituted or an aliphatic group which may be substituted, which are capable of e.g., inhibiting lipoperoxide formation.
    Type: Grant
    Filed: July 27, 1990
    Date of Patent: June 2, 1992
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Tetsuya Aono, Masahiro Suno, Go Kito
  • Patent number: 4956360
    Abstract: New thiazolo[5,4-b]azepine compounds represented by ##STR1## wherein R.sup.1 is a hydrogen atom, an aliphatic group which may be substituted, a carboxylic acyl group which may be substituted or a sulfonic acyl group which may be substituted; R.sup.2 is a hydrogen atom, an aromatic group which may be substituted or an aliphatic group which may be substituted, which are capable of e.g., inhibiting lipoperoxide formation.
    Type: Grant
    Filed: July 21, 1989
    Date of Patent: September 11, 1990
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Tetsuya Aono, Masahiro Suno, Go Kito